Concepedia

Morten Buus Jørgensen

MB

14

Publications

529

Citations

11

H-Index

1995

Active since

Affiliations

University of Copenhagen(Current)

Rigshospitalet

Gentofte Hospital

Copenhagen University Hospital

Herlev Hospital

Morten Buus Jørgensen is an author at University of Copenhagen specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1995–2023

14

Publications

14

Serum YKL-40: A new potential marker of prognosis and location of métastases of patients with recurrent breast cancer

Julia S. Johansen, C. Cintin, Morten Buus Jørgensen et al. · European Journal of Cancer · 1995 · 144 citations

, , +8

Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blind, Parallel-Group, Randomized Trial

Thomas Idorn, Filip K. Knop, Morten Buus Jørgensen et al. · Diabetes Care · 2015 · 90 citations

Plasma YKL‐40, as a prognostic tumor marker in recurrent ovarian cancer

Hannah Dehn, Estrid Høgdall, Julia S. Johansen et al. · Acta Obstetricia Et Gynecologica Scandinavica · 2003 · 80 citations

Elimination and Degradation of Glucagon-like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide in Patients with End-Stage Renal Disease

Thomas Idorn, Filip K. Knop, Morten Buus Jørgensen et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 39 citations · Full text

Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease

Thomas Idorn, Filip K. Knop, Morten Buus Jørgensen et al. · Kidney International · 2013 · 32 citations

, , +13

Rows per page

1–5 of 14